CRIS Current Research Information System

FARINA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.795
EU - Europa 6.166
AS - Asia 2.399
AF - Africa 357
Continente sconosciuto - Info sul continente non disponibili 25
SA - Sud America 19
OC - Oceania 14
Totale 17.775
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.776
GB - Regno Unito 1.761
CN - Cina 1.002
IT - Italia 978
DE - Germania 819
SE - Svezia 798
UA - Ucraina 530
SG - Singapore 529
VN - Vietnam 401
IN - India 332
IE - Irlanda 328
FR - Francia 251
RU - Federazione Russa 229
ZA - Sudafrica 130
EE - Estonia 124
TG - Togo 104
CH - Svizzera 85
BG - Bulgaria 51
SC - Seychelles 45
CI - Costa d'Avorio 42
FI - Finlandia 41
BE - Belgio 34
JP - Giappone 34
GR - Grecia 33
NG - Nigeria 23
NL - Olanda 22
EU - Europa 21
JO - Giordania 18
TR - Turchia 17
CA - Canada 16
IR - Iran 16
AT - Austria 15
RO - Romania 15
BR - Brasile 11
LB - Libano 10
AU - Australia 9
PL - Polonia 8
CZ - Repubblica Ceca 7
DK - Danimarca 7
MY - Malesia 7
NO - Norvegia 7
ES - Italia 6
LK - Sri Lanka 5
NZ - Nuova Zelanda 5
A2 - ???statistics.table.value.countryCode.A2??? 4
HU - Ungheria 4
MU - Mauritius 4
PH - Filippine 4
SA - Arabia Saudita 4
BD - Bangladesh 3
CL - Cile 3
CV - Capo Verde 3
CY - Cipro 3
IL - Israele 3
KR - Corea 3
MA - Marocco 3
PE - Perù 3
PT - Portogallo 3
RS - Serbia 3
CR - Costa Rica 2
EC - Ecuador 2
ID - Indonesia 2
MD - Moldavia 2
EG - Egitto 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
MX - Messico 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 17.775
Salva come PNG Salva come JPEG
Città #
Southend 1.517
Fairfield 1.344
Ashburn 729
Chandler 682
Woodbridge 645
Wilmington 570
Seattle 561
Houston 523
Singapore 457
Cambridge 415
Princeton 395
Jacksonville 385
Ann Arbor 358
Dublin 259
Dong Ket 242
Bologna 165
Nanjing 162
Westminster 161
Padova 153
Menlo Park 144
Berlin 123
Turin 108
Lomé 104
Santa Clara 90
San Diego 84
Shenyang 78
Jinan 76
Saint Petersburg 73
Milan 68
Mülheim 68
Nanchang 60
Bern 59
Beijing 54
Sofia 51
Boardman 49
Dearborn 46
Abidjan 42
Changsha 42
Des Moines 42
Hebei 42
Mahé 42
Florence 36
Helsinki 36
Olalla 33
Tianjin 33
Guangzhou 32
Brussels 31
Los Angeles 30
Tokyo 30
Verona 30
New York 26
Bremen 25
Jiaxing 25
Zhengzhou 25
Ningbo 24
Redwood City 24
Abeokuta 23
London 23
Redmond 22
Kuban 21
Medford 20
Rome 20
Taizhou 20
Frankfurt am Main 19
Amman 18
Haikou 18
Norwalk 18
Shanghai 18
Lanzhou 16
Hefei 15
Kunming 14
Bühl 13
Falls Church 13
Hangzhou 13
San Venanzo 13
Taiyuan 13
San Francisco 12
Fuzhou 11
Paris 11
Wuhan 11
Catania 9
Toronto 9
Vienna 9
Washington 9
Izmir 8
Lausanne 8
Shenzhen 8
Wenzhou 8
Amsterdam 7
Chengdu 7
Corbetta 7
Costa Mesa 7
Groningen 7
Kuala Lumpur 7
Mountain View 7
Munich 7
Brescia 6
Frankfurt Am Main 6
Oslo 6
Phoenix 6
Totale 12.251
Salva come PNG Salva come JPEG
Nome #
metodo e kit per la diagnosi prenatale di cardiopatie congenite 434
Fetal cardiac defects and third-trimester maternal serum placental growth factor 191
Circulating mRNA for the PLAC1 Gene as a Second Trimester Marker (14-18 Weeks' Gestation) in the Screening for Late Preeclampsia 178
Intrahepatic Cholestasis of Pregnancy: mRNAs for LIPF and ELOVL4 Genes Are Not Detectable in Circulating Maternal Plasma. 174
Accuracy of fetal gender determination in the first trimester using three-dimensional ultrasound. 171
Amniocentesis and chorionic villus sampling in twin gestations: which is the best sampling technique 170
Circulating corticotropin-releasing hormone mRNA in maternal plasma: relationship with gestational age and severity of preeclampsia. 163
IN GRAVIDANZE A TERMINE SOTTOPOSTE A INDUZIONE I LIVELLI DELL’mRNA DEL PLAC1 NEL SANGUE MATERNO SONO CORRELATI CON L’INTERVALLO DI TEMPO CHE INTERCORRE TRA LA PRIMA SOMMINISTRAZIONE DI GEL A BASE DI DINOPROSTONE E IL PARTO 162
PLAC1 mRNA in maternal blood correlates with Doppler waveform in uterine arteries in normal pregnancies at the second and third trimester. 161
Brainstem-vermis and brainstem-tentorium angles allow accurate categorization of fetal upward rotation of cerebellar vermis 161
Prenatal diagnosis of a complete mole coexisting with a dichorionic twin pregnancy: case report. 157
Heat shock response by EBV-immortalized B-lymphocytes from centenarians and control subjects: A model to study the relevance of stress response in longevity 154
Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy. 153
P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study. 153
Matrix metalloproteinase-3 mRNA: a promising peripheral blood marker for diagnosis of endometriosis. 153
High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy 146
Dynamic changes of fetal head descent at term before the onset of labor correlate with labor outcome and can be improved by ultrasound visual feedback 144
Performance of peripheral (serum and molecular) blood markers for diagnosis of endometriosis. 143
Changes in Vaginal Physiology of Menopausal Women with Type 2 Diabetes 139
Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of preeclampsia to the collection of blood. 137
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 136
Analysis of the ultrasonographic findings predictive of vasa previa. 132
Velamentous cord insertion and atypical variable decelerations with no accelerations. 131
The impact of assisted reproductive technology and chorionicity in twin pregnancies complicated by obstetric cholestasis 131
Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia. 130
Akt, protein kinase C, and mitogen-activated protein kinase phosphorylation status in head and neck squamous cell carcinoma. 130
Biophysical markers for abnormal placentation: first and/or second trimester 129
Congenital heart defects: is it time to explore maternal blood for a non-invasive genetic screening test? 127
Prognostic value of pelvic lymphadenectomy in surgical treatment of apparent stage I endometrial cancer. 127
Total activin A in maternal blood as a marker of preterm delivery in low-risk asymptomatic patients 127
Ultrasound prediction of symptomatic congenital cytomegalovirus infection 127
Cellular mRNA expressions of anti-oxidant factors in the blood of preeclamptic women. 127
Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop preeclampsia later in pregnancy: implications for screening. 126
Identification of circulating placental mRNA in maternal blood of pregnancies affected with fetal congenital heart diseases at the second trimester of pregnancy: implications for early molecular screening. 126
null 125
Cell-Free DNA (cfDNA) Fetal Fraction in Early- and Late-Onset Fetal Growth Restriction 125
Antioxidant supplementation in pregnant women with low antioxidant status. 124
Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop pre-eclampsia later in pregnancy: implications for screening. 123
Bcl-2 as prognostic factor in head and neck squamous cell carcinoma. 123
Evidence of genetic underexpression in chorionic villi samples of euploid fetuses with increased nuchal translucency at 10-11 weeks' gestation 122
Delivery and immigration: the experience of an Italian hospital. 122
Fragmentation of cell-free fetal DNA in plasma and urine of pregnant women. 121
Vaginal cuff dehiscence after hysterectomy: a multicenter retrospective study. 121
Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. 118
Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia. 118
A First-Trimester Biomarker Panel for Predicting the Development of Gestational Diabetes 118
Cord insertion into the lower third of the uterus in the first trimester is associated with placental and umbilical cord abnormalities 116
Umbilical cord insertion into the lower segment of the uterus at 11 to 13 weeks' gestation is associated with maternal serum PAPP-A. 115
Circulating mRNA for epidermal growth factor-like domain 7 (EGFL7) in maternal blood and early intrauterine growth restriction. A preliminary analysis 115
An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens 115
Gene Expression Profile Analysis in Human T Lymphocytes from Patients with Down Syndrome. 114
Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. 114
Clinical outcome of 285 Medpor grafts used for craniofacial reconstruction. 113
Higher circulating mRNA levels of placental specific genes in a patient with placenta accreta. 113
PLAC1 mRNA levels in maternal blood at induction of labor correlate negatively with induction-delivery interval. 113
Time profile of appearance and disappearance of circulating placenta-derived mRNA in maternal plasma. 112
Cell-Free Fetal DNA for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-Analysis 112
Circulating mRNA in Maternal Plasma at the Second Trimester of Pregnancy: A Possible Screening Tool for Cardiac Conotruncal and Left Ventricular Outflow Tract Abnormalities 112
Caesarean scar pregnancy complicated by placenta percreta followed by suppurative appendicitis after conservative management with methotrexate 112
Prospective evaluation of the risk of pre-eclampsia using logistic regression analysis. 110
Elevated maternal placental protein 13 serum levels at term of pregnancy in postpartum major hemorrhage (>1000 mLs). A prospective cohort study 110
PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia. 108
Time remaining in labor and probability of vaginal delivery as a function of the angle of progression in a low risk population with a normal first stage of labor. In-house observational study and comparison with the data in the literature 108
Multivariable evaluation of term birth weight: a comparison between ultrasound biometry and symphysis-fundal height 107
Delaire's cheilorhinoplasty: Unilateral cleft aesthetic outcome scored according to the EUROCLEFT guidelines 106
Ultrasound screening for congenital pyelectasis in term pregnancies 106
Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women. 104
Rapid clearance of mRNA for PLAC1 gene in maternal blood after delivery. 104
The Tei index for evaluation of fetal myocardial performance in sick fetuses 103
Non-syndromic orofacial clefts in Southern Italy: pattern analysis according to gender, history of maternal smoking, folic acid intake and familial diabetes. J Craniomaxillofac Surg. 103
Cell-free mRNA concentrations of plasminogen activator inhibitor-1 andtissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia. 103
Predisposing factors for massive hemorrhage during Cesarean section in patients with placenta previa 103
BASSI LIVELLI DI mRNA PER IL GENE PLAC1 NELLE GRAVIDANZE COMPLICATE DA PERDITE EMATICHE VAGINALI (MINACCIA D’ABORTO <20 SETTIMANE) MA CON SOPRAVVIVENZA FETALE 103
Lower maternal PLAC1 mRNA in pregnancies complicated with vaginal bleeding (threatened abortion <20 weeks) and a surviving fetus. 103
PLAC1 (Placenta-specific 1): a novel, X-linked gene with roles in reproductive and cancer biology 102
Measurement of mRNA of trophoblast-specific genes in cellular and plasma components of maternal blood. 101
pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance 101
Development of noninvasive fetal DNA diagnosis from nucleated erythrocytes circulating in maternal blood. 100
IMPATTO DELLE INDAGINI DIAGNOSTICHE DI APPROFONDIMENTO E DEL COUNSELLING SULLA PERCENTUALE DI INTERRUZIONI VOLONTARIE DI GRAVIDANZA NELLE DONNE CON RISCONTRO DI IMMUNOGLOBULINE M ANTI-CITOMEGALOVIRUS AL TEST DI SCREENING 99
TGF Alpha Has Low Protein Expression in Nonsyndromic Clefts. 99
Infezione da HIV e gravidanza: profilassi versus terapia antiretrovirale altamente efficace 99
Diagnosis of station and rotation of the fetal head in the second stage of labor with intrapartum translabial ultrasound. 99
Normal morphometry of fetal posterior fossa at midtrimester: brainstem-tentorium angle and brainstem-vermis angle. 99
P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation 99
Levels of Circulating mRNA for the Tenascin-X (TNXB) Gene in Maternal Plasma at the Second Trimester in Pregnancies with Isolated Congenital Ventricular Septal Defects 99
Prediction of pre-eclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15-20 weeks of gestation 98
Effect of c-Met expression on survival in head and neck squamous cell carcinoma. 97
Clinical potential for noninvasive prenatal diagnosis through detection of fetal cells in maternal blood 97
Malignant transformation of endometriosis: application of laser microdissection for analysis of genetic alterations according to pathological changes 97
Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks' gestation. 97
beta-globin DNA in maternal plasma as a molecular marker of pre-eclampsia. 97
Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks. 97
Three-dimensional ultrasound is an accurate and reproducible technique for fetal crown-rump length measureme 96
Elevated levels of total (maternal and fetal) beta-globin DNA in maternal blood from first trimester pregnancies with trisomy 21. 95
The First Case Report in Italy of Di George Syndrome Detected by Noninvasive Prenatal Testing 95
Effect of p63 expression on survival in oral squamous cell carcinoma. 94
PP13 mRNA Expression in Trophoblasts From Preeclamptic Placentas. 93
Uterine artery Doppler longitudinal changes in pregnancies complicated with intrauterine growth restriction without preeclampsia 93
Placental vascular indices (VI, FI and VFI) in intrauterine growth retardation (IUGR). A pooled analysis of the literature 93
Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood. 92
Totale 12.295
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.622
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 211
Totale 47.833
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.354 0 0 0 344 563 596 662 747 631 345 158 308
2020/20212.580 527 222 104 125 68 135 47 186 212 171 168 615
2021/20223.155 201 91 240 359 317 151 86 229 114 185 599 583
2022/20233.300 395 479 193 399 210 236 91 175 490 116 342 174
2023/2024892 94 157 81 94 78 130 45 64 24 49 29 47
2024/20251.127 155 553 318 101 0 0 0 0 0 0 0 0
Totale 18.226